AEON - AEON Biopharma, Inc.

Day 1m 10m 60m PreMarket Market AfterHours Gap
0.82 0.0 (0.0%) --- --- 0.0 (0.35%) -0.01 (-0.61%) 0.02 (1.9%) 0.01 (0.98%) -0.02 (-1.81%)

AEON Biopharma Inc is a clinical stage biopharmaceutical company focused on developing of its proprietary botulinum toxin complex ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, with an initial focus on the neurosciences market.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Market

Earnings & Ratios

Basic EPS:
-0.6
Diluted EPS:
-0.6
Basic P/E:
-1.3666
Diluted P/E:
-1.3666
RSI(14) 1m:
13.94
VWAP:
0.82
RVol:

Events

Period Kind Movement Occurred At

Related News